SAPHEON / MEDTRONIC VENASEAL CLOSURE SYSTEM-CE MARK; AGENT, OCCLUDING, VASCULAR, PERMANENT,
|
Back to Search Results |
|
Model Number SP-101 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Reaction (2414)
|
Event Date 07/04/2014 |
Event Type
Injury
|
Event Description
|
Patient presented with an insufficient great saphenous vein (gsv).The physician treated the vein with the venaseal closure system from the sapheno-femoral junction (sfj) using 1.7 ml venaseal cyanoacrylate adhesive.The intervention was uneventful.No additional compression therapy was administered.Examination on first post-operative day and at the two week follow-up period showed a fully closed gsv, however the patient reported some itching on the inner surface of his lower extremities.The ultrasound examination revealed a diffuse liquid-orbit around the gsv.The patient consulted with a dermatologist after reoccurring itching on both legs and arm surfaces.Nine months a full allergy diagnostic was performed using a prick test with exposition of cyanoacrylate to one arm of the patient.After two days no explicit reaction could be detected, but after two weeks they achieved a positive result of an allergic reaction type 1, that was successfully treated with xusal.Re-examination a number of weeks later showed a good response to the treatment, with no liquid assembly around the gsm, no bruising or itching.
|
|
Manufacturer Narrative
|
(b)(4).A capa has been opened to manage the actions related to remediation of complaint files and any required mdr reporting.
|
|
Manufacturer Narrative
|
After review of the manufacturing report number, it was determined that the mdr was submitted under the incorrect number.The original manufacturing report number that was generated was 1282497-2015-00002, which should have been 3011410703-2015-0002.The original mdr number 1282497-2015-00002 was submitted by the correct due date of june 6, 2015, with a receipt message id: (b)(4).
|
|
Event Description
|
This procedure was performed in (b)(6).Customer states that the patient was treated with the venaseal closure system six months ago (somewhere in (b)(6) 2014).He has shown an allergically reaction type 1 with hives.Now he is treated with histamine antagonist.Procedure: cvi treatment.With non-thermal, non-tumescence, endoluminal technique.No further intervention required.Device destroyed by user.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|